|Alicia D Henn, PhD, MBA|
About the Author
Alicia Henn has been the Chief Scientific Officer of BioSpherix, Ltd for
two years. Previously, she was a researcher at the Center for
Biodefense Immune Modeling in Rochester, NY. Alicia obtained
her PhD in molecular pharmacology and cancer therapeutics from
Roswell Park Cancer Institute in Buffalo, NY and her MBA from the
Simon School at University of Rochester in Rochester, NY.